Jean-Michel Vernier

Jean-Michel Vernier

Corporate Officer/Principal at Ignyta Operating, Inc.

63 year
Health Technology
Consumer Services

Profile

Jean-Michel Vernier is the founder of Selexagen Therapeutics, Inc. He currently holds the position of Vice President-Medicinal Chemistry at Ignyta Operating, Inc. Vernier has previously worked as Associate Director-Chemistry at Bausch Health Americas, Inc., Senior Research Scientist at Sibia Neurosciences, Inc., Vice President-Discovery Chemistry at Ardea Biosciences, Inc., and Senior Chemistry Investigator at Merck Research Laboratories Massachusetts LLC.
He has also held the position of Head-Medicinal Chemistry at Aravive Biologics, Inc. from 2012 to 2013 and Vice President-Chemistry Department at Ignyta, Inc. from 2013 to 2018.
Vernier holds a doctorate degree from the University of Strasbourg.

Jean-Michel Vernier active positions

CompaniesPositionStart
Corporate Officer/Principal 2013-05-31
All active positions of Jean-Michel Vernier

Former positions of Jean-Michel Vernier

CompaniesPositionEnd
IGNYTA INC Corporate Officer/Principal 2018-11-30
Corporate Officer/Principal 2013-03-31
Sibia Neurosciences, Inc. Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Jean-Michel Vernier's experience

Training of Jean-Michel Vernier

University of Strasbourg Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jean-Michel Vernier's experience

Connections

28

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Selexagen Therapeutics, Inc.

Health Technology

Health Technology

Sibia Neurosciences, Inc.

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Jean-Michel Vernier